BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 25692402)

  • 1. Induction of STAT3-Dependent CXCL5 Expression and Neutrophil Recruitment by Oncostatin-M during Pneumonia.
    Traber KE; Hilliard KL; Allen E; Wasserman GA; Yamamoto K; Jones MR; Mizgerd JP; Quinton LJ
    Am J Respir Cell Mol Biol; 2015 Oct; 53(4):479-88. PubMed ID: 25692402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alveolar epithelial STAT3, IL-6 family cytokines, and host defense during Escherichia coli pneumonia.
    Quinton LJ; Jones MR; Robson BE; Simms BT; Whitsett JA; Mizgerd JP
    Am J Respir Cell Mol Biol; 2008 Jun; 38(6):699-706. PubMed ID: 18192501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophil-Derived Oncostatin M Triggers Diverse Signaling Pathways during Pneumonia.
    Traber KE; Dimbo EL; Shenoy AT; Symer EM; Allen E; Mizgerd JP; Quinton LJ
    Infect Immun; 2021 Mar; 89(4):. PubMed ID: 33526570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of interleukin-6 in activation of STAT proteins and recruitment of neutrophils during Escherichia coli pneumonia.
    Jones MR; Quinton LJ; Simms BT; Lupa MM; Kogan MS; Mizgerd JP
    J Infect Dis; 2006 Feb; 193(3):360-9. PubMed ID: 16388483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-17A and TNF-α exert synergistic effects on expression of CXCL5 by alveolar type II cells in vivo and in vitro.
    Liu Y; Mei J; Gonzales L; Yang G; Dai N; Wang P; Zhang P; Favara M; Malcolm KC; Guttentag S; Worthen GS
    J Immunol; 2011 Mar; 186(5):3197-205. PubMed ID: 21282514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncostatin M promotes proliferation of ovarian cancer cells through signal transducer and activator of transcription 3.
    Li Q; Zhu J; Sun F; Liu L; Liu X; Yue Y
    Int J Mol Med; 2011 Jul; 28(1):101-8. PubMed ID: 21399864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A dual role for oncostatin M signaling in the differentiation and death of mammary epithelial cells in vivo.
    Tiffen PG; Omidvar N; Marquez-Almuina N; Croston D; Watson CJ; Clarkson RW
    Mol Endocrinol; 2008 Dec; 22(12):2677-88. PubMed ID: 18927239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of CXCL5 during inflammation in the rodent lung involves activation of alveolar epithelium.
    Jeyaseelan S; Manzer R; Young SK; Yamamoto M; Akira S; Mason RJ; Worthen GS
    Am J Respir Cell Mol Biol; 2005 Jun; 32(6):531-9. PubMed ID: 15778492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncostatin M modulates fibroblast function via signal transducers and activators of transcription proteins-3.
    Nagahama KY; Togo S; Holz O; Magnussen H; Liu X; Seyama K; Takahashi K; Rennard SI
    Am J Respir Cell Mol Biol; 2013 Oct; 49(4):582-91. PubMed ID: 23668543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monocyte chemoattractant protein 1 regulates pulmonary host defense via neutrophil recruitment during Escherichia coli infection.
    Balamayooran G; Batra S; Balamayooran T; Cai S; Jeyaseelan S
    Infect Immun; 2011 Jul; 79(7):2567-77. PubMed ID: 21518788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of IL-17A responses in human airway smooth muscle cells by Oncostatin M.
    Kwofie K; Scott M; Rodrigues R; Guerette J; Radford K; Nair P; Richards CD
    Respir Res; 2015 Feb; 16(1):14. PubMed ID: 25849622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncostatin M-induced blood-brain barrier impairment is due to prolonged activation of STAT3 signaling in vitro.
    Takata F; Dohgu S; Matsumoto J; Machida T; Sakaguchi S; Kimura I; Yamauchi A; Kataoka Y
    J Cell Biochem; 2018 Nov; 119(11):9055-9063. PubMed ID: 30076740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel function of Oncostatin M as a potent tumour-promoting agent in lung.
    Lauber S; Wong S; Cutz JC; Tanaka M; Barra N; Lhoták S; Ashkar A; Richards CD
    Int J Cancer; 2015 Feb; 136(4):831-43. PubMed ID: 24976180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stat3-coordinated Lin-28-let-7-HMGA2 and miR-200-ZEB1 circuits initiate and maintain oncostatin M-driven epithelial-mesenchymal transition.
    Guo L; Chen C; Shi M; Wang F; Chen X; Diao D; Hu M; Yu M; Qian L; Guo N
    Oncogene; 2013 Nov; 32(45):5272-82. PubMed ID: 23318420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. STAT3-mediated SMAD3 activation underlies Oncostatin M-induced Senescence.
    Bryson BL; Junk DJ; Cipriano R; Jackson MW
    Cell Cycle; 2017 Feb; 16(4):319-334. PubMed ID: 27892764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXCL1 regulates neutrophil homeostasis in pneumonia-derived sepsis caused by
    Paudel S; Baral P; Ghimire L; Bergeron S; Jin L; DeCorte JA; Le JT; Cai S; Jeyaseelan S
    Blood; 2019 Mar; 133(12):1335-1345. PubMed ID: 30723078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncostatin M-dependent Mcl-1 induction mediated by JAK1/2-STAT1/3 and CREB contributes to bioenergetic improvements and protective effects against mitochondrial dysfunction in cortical neurons.
    Chang SH; Hwang CS; Yin JH; Chen SD; Yang DI
    Biochim Biophys Acta; 2015 Oct; 1853(10 Pt A):2306-25. PubMed ID: 25986861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncostatin M differentially regulates CXC chemokines in mouse cardiac fibroblasts.
    Lafontant PJ; Burns AR; Donnachie E; Haudek SB; Smith CW; Entman ML
    Am J Physiol Cell Physiol; 2006 Jul; 291(1):C18-26. PubMed ID: 16452159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncostatin-M-Reactive Pericytes Aggravate Blood-Brain Barrier Dysfunction by Activating JAK/STAT3 Signaling In Vitro.
    Takata F; Dohgu S; Sakaguchi S; Sakai K; Yamanaka G; Iwao T; Matsumoto J; Kimura I; Sezaki Y; Tanaka Y; Yamauchi A; Kataoka Y
    Neuroscience; 2019 Dec; 422():12-20. PubMed ID: 31705893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncostatin M secreted by skin infiltrating T lymphocytes is a potent keratinocyte activator involved in skin inflammation.
    Boniface K; Diveu C; Morel F; Pedretti N; Froger J; Ravon E; Garcia M; Venereau E; Preisser L; Guignouard E; Guillet G; Dagregorio G; Pène J; Moles JP; Yssel H; Chevalier S; Bernard FX; Gascan H; Lecron JC
    J Immunol; 2007 Apr; 178(7):4615-22. PubMed ID: 17372020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.